Clover Health Investments (CLOV) Competitors $2.57 -0.05 (-1.91%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$2.62 +0.05 (+1.75%) As of 08:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLOV vs. ESNT, ACT, FG, BWIN, HGTY, OSCR, PLMR, GSHD, NMIH, and CSShould you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Essent Group (ESNT), Enact (ACT), F&G Annuities & Life (FG), Baldwin Insurance Group (BWIN), Hagerty (HGTY), Oscar Health (OSCR), Palomar (PLMR), Goosehead Insurance (GSHD), NMI (NMIH), and Credit Suisse Group (CS). These companies are all part of the "insurance" industry. Clover Health Investments vs. Its Competitors Essent Group Enact F&G Annuities & Life Baldwin Insurance Group Hagerty Oscar Health Palomar Goosehead Insurance NMI Credit Suisse Group Essent Group (NYSE:ESNT) and Clover Health Investments (NASDAQ:CLOV) are both insurance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment. Do insiders & institutionals hold more shares of ESNT or CLOV? 93.0% of Essent Group shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 2.9% of Essent Group shares are held by company insiders. Comparatively, 24.1% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better earnings and valuation, ESNT or CLOV? Essent Group has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Essent Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEssent Group$1.24B4.98$729.40M$6.859.18Clover Health Investments$1.37B0.95-$43.01M-$0.08-32.13 Do analysts recommend ESNT or CLOV? Essent Group currently has a consensus target price of $63.67, suggesting a potential upside of 1.29%. Clover Health Investments has a consensus target price of $4.37, suggesting a potential upside of 69.91%. Given Clover Health Investments' stronger consensus rating and higher possible upside, analysts clearly believe Clover Health Investments is more favorable than Essent Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Essent Group 0 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Clover Health Investments 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer ESNT or CLOV? In the previous week, Essent Group had 21 more articles in the media than Clover Health Investments. MarketBeat recorded 31 mentions for Essent Group and 10 mentions for Clover Health Investments. Essent Group's average media sentiment score of 0.59 beat Clover Health Investments' score of 0.45 indicating that Essent Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Essent Group 9 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Clover Health Investments 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Is ESNT or CLOV more profitable? Essent Group has a net margin of 56.36% compared to Clover Health Investments' net margin of -2.68%. Essent Group's return on equity of 12.66% beat Clover Health Investments' return on equity.Company Net Margins Return on Equity Return on Assets Essent Group56.36% 12.66% 9.98% Clover Health Investments -2.68%-12.20%-6.95% Which has more volatility and risk, ESNT or CLOV? Essent Group has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. SummaryEssent Group beats Clover Health Investments on 11 of the 16 factors compared between the two stocks. Get Clover Health Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLOV vs. The Competition Export to ExcelMetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.33B$2.02B$5.61B$9.84BDividend YieldN/AN/A4.61%4.07%P/E Ratio-32.1332.0030.2925.74Price / Sales0.959.82469.53115.79Price / CashN/A51.7138.2159.48Price / Book3.785.778.846.15Net Income-$43.01M-$62.35M$3.25B$265.06M7 Day Performance17.89%3.23%3.74%2.60%1 Month Performance-13.76%-0.54%5.88%2.83%1 Year Performance-3.38%21.06%30.27%25.58% Clover Health Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLOVClover Health Investments2.5391 of 5 stars$2.57-1.9%$4.37+69.9%+2.4%$1.33B$1.37B-32.13680ESNTEssent Group4.3763 of 5 stars$56.89+0.7%$63.71+12.0%+6.1%$5.77B$1.24B8.33350Trending NewsEarnings ReportDividend AnnouncementAnalyst DowngradeInsider TradeAnalyst RevisionACTEnactN/A$35.36+0.7%$35.00-1.0%+15.0%$5.31B$1.20B8.05500FGF&G Annuities & Life4.5087 of 5 stars$31.70+1.0%$43.33+36.7%-8.9%$4.27B$4.76B8.411,338Analyst UpgradeBWINBaldwin Insurance Group3.8966 of 5 stars$36.01+2.0%$45.17+25.4%-18.9%$4.27B$1.39B-69.254,116Positive NewsHGTYHagerty1.8706 of 5 stars$10.74+7.2%$10.50-2.2%+5.6%$3.67B$1.25B53.711,744Insider TradeOSCROscar Health1.9109 of 5 stars$13.85+2.0%$12.21-11.8%-19.3%$3.53B$10.08B49.462,400Analyst ForecastPLMRPalomar4.3143 of 5 stars$131.53+1.5%$174.17+32.4%+33.5%$3.52B$609.96M26.25150Short Interest ↓GSHDGoosehead Insurance4.4159 of 5 stars$88.65+3.4%$109.50+23.5%+2.3%$3.33B$341.57M78.451,580Analyst ForecastInsider TradeNMIHNMI2.5866 of 5 stars$37.60+1.1%$42.33+12.6%+6.4%$2.92B$679.62M7.98234CSCredit Suisse GroupN/A$0.89flatN/AN/A$2.77B$22.88B1.3750,480 Related Companies and Tools Related Companies Essent Group Alternatives Enact Alternatives F&G Annuities & Life Alternatives Baldwin Insurance Group Alternatives Hagerty Alternatives Oscar Health Alternatives Palomar Alternatives Goosehead Insurance Alternatives NMI Alternatives Credit Suisse Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLOV) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access